Investor News & Updates

two people talking in front of bayer logo

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

1 - 10of 475 News
1 - 10of 475 News
June 17, 2026
Not intended for UK Media
Bayer completes acquisition of Perfuse Therapeutics
READ MORE
June 15, 2026
Bayer’s low-dose MRI contrast agent approved in U.S.
READ MORE
June 10, 2026
European Medicines Agency confirms Bayer’s FXIa inhibitor marketing authorization application for assessment in secondary prevention of ischemic stroke
READ MORE
June 09, 2026
Jana Marlen Ackermann to be new Head of Investor Relations at Bayer
READ MORE
May 19, 2026
Not intended for U.S. and UK Media
New drug applications for Bayer’s FXIa inhibitor accepted by U.S. Food and Drug Administration under Priority Review and by Japan’s Ministry of Health, Labour and Welfare
READ MORE
May 12, 2026
First quarter of 2026:
Bayer reports solid start to the year and confirms currency-adjusted Group guidance for 2026
READ MORE
May 06, 2026
Not intended for UK Media
Bayer to acquire Perfuse Therapeutics to complement ophthalmology pipeline
READ MORE
April 29, 2026
Not intended for U.S. and UK Media
China’s Center of Drug Evaluation accepts marketing authorization application for Bayer’s FXIa inhibitor in stroke prevention after a non-cardioembolic ischemic stroke or transient ischemic attack
READ MORE
April 24, 2026
Bayer CEO Bill Anderson at the Annual Stockholders’ Meeting:
“We see great progress, but the work isn’t complete yet”
READ MORE
April 16, 2026
Not intended for U.S. and UK Media
Phase III study results with Bayer’s FXIa inhibitor demonstrating substantial reduction in ischemic stroke with no increase in ISTH major bleeding versus placebo published in New England Journal of Medicine
READ MORE
1 - 10of 475 News
1 - 10of 475 News
Inform Yourself on Special Topics
Control Weeds Not Farming

Control Weeds, Not Farming

LEARN MORE
Farmers discussing their weed management

Everything You Need to Know About Glyphosate

LEARN MORE
some-bayer-group-headquarters

Managing Glyphosate Litigation

learn more
woman harvesting carrots

Managing and Mitigating PCB Litigation Risk

learn more